Edition:
United Kingdom

People: Bioton SA (BIOP.WA)

BIOP.WA on Warsaw Stock Exchange

4.23PLN
24 May 2019
Change (% chg)

-0.07zł (-1.63%)
Prev Close
4.30zł
Open
4.26zł
Day's High
4.30zł
Day's Low
4.23zł
Volume
20,238
Avg. Vol
33,621
52-wk High
7.65zł
52-wk Low
4.22zł

Liu, Jubo 

Dr. Jubo Liu has served as Chairman of the Supervisory Board of Bioton S.A. since May 15, 2017. He has previously been Chairman of the Management Board since November 26, 2016. He was Chairman of the Supervisory Board and Acting Chairman of the Management Board of the Company from October 4, 2016. Prior to that, from February 23, 2016 he was Chairman of the Supervisory Board at the Company. He was Member of the Supervisory Board of the Company from February 22, 2016. He has been Vice Chairman of the Audit Committee of the Company since May 15, 2017. He is founder and Chairman of Cogenes Biotechnology Incorporation, as well as founder of NovoTek Pharmaceuticals Limited and Beijing NovoTek Medicinal Technology Development Co. Ltd. During his professional career, he served at Immtech Pharmaceuticals Inc., Pharmaceuticals Inc., Boston Vertex Pharmaceuticals Inc. and Beijing Huayuanlong Medicinal Technology Development Co. Ltd. He holds Bachelor’s degree in Pharmacy from Shenyang Pharmaceutical University and Ph.D. degree from University of Toronto.

Basic Compensation

Total Annual Compensation, PLN 310,000
Restricted Stock Award, PLN --
Long-Term Incentive Plans, PLN --
All Other, PLN --
Fiscal Year Total, PLN 310,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jubo Liu

310,000

Robert Neymann

640,000

Dariusz Trzeciak

40,000

Vaidyanathan Viswanath

24,000

Adam Polonek

1,111,000

Qi Bo

6,000
As Of  31 Dec 2017